We have assessed the interference of acetylsalicylic acid (aspirin) with some common clinical laboratory assays, because of its widespread use and reported interference. The therapeutic regimens involved ingestion of 10 325-mg tablets daily for three days or eight tablets for five days or two weeks. Twenty-one commonly done determinations were run on control sera, and sera were collected during and after drug therapy. Significant changes in t-test values, indicating the significance of the standard deviation of the difference between controls and specimens drawn after drug therapy, were observed for chloride (increased), and for total protein, calcium, cholesterol, uric acid, bilirubin, and thyroxine (decreased). Aspirin therapy depressed the apparent concentrations of these constituents progressively in the three-day regimen and initially in the long-term regimens, followed by recovery toward zero t-values at the end of the longer regimens.
and thyroxine (decreased). Aspirin therapy depressed the apparent concentrations of these constituents progressively in the three-day regimen and initially in the long-term regimens, followed by recovery toward zero t-values at the end of the longer regimens. There have been few attempts to quantitate the effect of a drug on clinical chemistry determinations. There are obviously many problems involved in such a study, but we have started to explore this field. The drug chosen for study was acetylsalicylic acid (aspirin) for three major reasons: (a) aspirin ingestion reportedly affects a number of laboratory determinations; (b) our laboratory has more than 30 years of research experience with the chemistry, methodology, and metabolism of the drug; and (c) people often ingest aspirin without being aware that it is a drug, and so may neglect to mention it when asked about drugs taken. It is difficult to estimate the number of apparently normal patients whose blood specimens contain salicylates when drawn for laboratory profiles. The large number of over-thecounter medications that contain aspirin and are used for self-medication compounds this problem. Two major factors must be taken into account in exploratory studies:
AdditionalKeyphrases
the therapeutic regimen and the salicylate concentrations in the blood. In the present study we used apparently normal subjects (laboratory and hospital personnel), who followed four different regimens of aspirin ingestion. Serum was sampled at the beginning and during each regimen and analyzed for total salicylates and for 13 to 20 biochemical constituents. #{149} All values are expressed in mg/dl except salicylate is in tgIml, T-4 in !Lg/100 ml, T-3 in % uptake, amylase in Somogyi units/100 ml, and alk. phos.. LDH, and AST in U/liter. I 2.08 at 95% level. The second regimen was a short-term, intensive dosage to simulate that practiced by many people as therapy for influenza or coryza: two 325-mg aspirin tablets were ingested every 4 h (0800, 1200, 1600, 2000, and 2400 hours) for three days by 22 subjects. A control specimen and specimens at 0800 hours on the following three days (before aspirin ingestion)
Methods

Serum
were drawn before the first meal of the day. Table 1 in an amount equal to the concentration of total salicylate on the third day, directly to the control sera of 15 of the 22 subjects.
The only values significantly affected by direct addition of salicylate to the serum control were those for albumin, a result of interference by salicylate with the binding of "HABA" dye by the albumin.2 (A method using bromcresol green was used throughout the remaining studies.) The third regimen involved 20 subjects, who ingested eight 325-mg aspirin tablets daily (two at 0800, 1200, 1600, and 2000 hours) for five days, followed by eight days during which no aspirin was ingested and then another five-day period similar to the first. Blood samples were drawn for each control period and at the end of each five-day period. Table 2 shows the results of the analysis for total salicylate and 19 other constituents. Of the 38 t-test values, 17 were significant, with 12 showing a decrease and five an increase. Total protein and uric acid exhibited significant decreases during both five-day periods, while values for cholesterol, bilirubin, aspartate aminotransferase, Na, amylase, arid thyroxine decreased significantly in the first but not in the last five-day period.
A smaller group (13 subjects) was used to study effects of long-term aspirin therapy similar to that followed by patients with arthritis.
They ingested two 325-mg aspirin tablets four times a day (at 0800, 1200, 1600, and 2000 hours) for two weeks, ingested no aspirin for one week, and then repeated the two-week regimen. Blood was sampled at the beginning of each period and at the end of the first, second, third, and fourth weeks on aspirin therapy. 
T-4
Det.rmlnatlon first three, alkaline phosphatase in the first two weeks, bilirubin and potassium during the third and fourth weeks, thyroxine during the first and third, and cholesterol in the first week. Chloride showed a significant increase over the control period in the first and second weeks.
Total protein Albumin
The salicylate concentrations in the serum specimens for each subject in the four regimens were measured, and the data are available. 2 Mean serum salicylate values for the different regimens are summarized in Table 4 . Because specimens for analysis were drawn before 0800 hours on each control or sample day or week, the salicylate values are low, and in the case of the last three regimens represent concentrations in serum about 8 to 12 h after aspirin ingestion.
Discussion
To facilitate comparison of the last three therapeutic regimens, Table 5 lists the t -values for the 3-day, 5-day, and 2-week periods. The changes in the six constituents, which demonstrate five or more significant differences in a negative direction (total protein, calcium, cholesterol, uric acid, bilirubin, and thyroxine) and in chloride, which shows five differences in a positive direction, are expressed graphically in Figure 1 . (This method was changed after the second regimen.) The recent tabulation of drug effects (6) lists only one methodological interference applicable to the seven constituents in Figure 1 : a decrease in calcium caused by a depression of the fluorescence of calcein. Such an interference was not uniform in the present study, especially in the short-term regimens (Tables 1 and 2 ). The changes summarized in Table 5 Evidently aspirin therapy depresses the values for the six constituents progressively in the three-day regimen and initially in the first five days or first week of the two-week regimens. This is followed by a recovery toward zero t -values at the end of 10 days or the second week of each two-week period. Because the t -values are the lowest after three days, five days, or one week, it must take the physiological mechanisms of the body a reasonably long time to adjust to aspirin therapy.
